Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/febs.15625

http://scihub22266oqcxt.onion/10.1111/febs.15625
suck pdf from google scholar
33185982!8359365!33185982
unlimited free pdf from europmc33185982    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33185982      FEBS+J 2021 ; 288 (12): 3715-3726
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Interferon-stimulated gene products as regulators of central carbon metabolism #MMPMID33185982
  • Ebrahimi KH; Gilbert-Jaramillo J; James WS; McCullagh JSO
  • FEBS J 2021[Jun]; 288 (12): 3715-3726 PMID33185982show ga
  • In response to viral infections, the innate immune system rapidly activates expression of several interferon-stimulated genes (ISGs), whose protein and metabolic products are believed to directly interfere with the viral life cycle. Here, we argue that biochemical reactions performed by two specific protein products of ISGs modulate central carbon metabolism to support a broad-spectrum antiviral response. We demonstrate that the metabolites generated by metalloenzymes nitric oxide synthase and the radical S-adenosylmethionine (SAM) enzyme RSAD2 inhibit the activity of the housekeeping and glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH). We discuss that this inhibition is likely to stimulate a range of metabolic and signalling processes to support a broad-spectrum immune response. Based on these analyses, we propose that inhibiting GAPDH in individuals with deteriorated cellular innate immune response like elderly might help in treating viral diseases such as COVID-19.
  • |Antiviral Agents/*metabolism/pharmacology[MESH]
  • |COVID-19/prevention & control/virology[MESH]
  • |Carbon/*metabolism[MESH]
  • |Cells, Cultured[MESH]
  • |Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)/metabolism[MESH]
  • |HEK293 Cells[MESH]
  • |Humans[MESH]
  • |Immunity, Innate/drug effects[MESH]
  • |Induced Pluripotent Stem Cells/metabolism[MESH]
  • |Interferons/*metabolism[MESH]
  • |Macrophages/metabolism[MESH]
  • |Models, Biological[MESH]
  • |Oxidoreductases Acting on CH-CH Group Donors[MESH]
  • |Proteins/genetics/*metabolism[MESH]
  • |S-Adenosylmethionine/*metabolism[MESH]
  • |SARS-CoV-2/drug effects/physiology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box